A clinical evaluation of bleeding patterns, adverse effects, and satisfaction with the subdermal etonogestrel implant among postpartum and non-postpartum users
The etonogestrel implant (Implanon; Merck Sharp and Dohme, Kenilworth, NJ, USA) is an effective contraceptive with a good safety profile for up to 3 years [1]. However, its adverse effects include irregular vaginal bleeding (affecting 68.0% of users), weight gain (20.7%), acne (15.3%), breast pain (...
Saved in:
相似书籍
-
Evaluation of bleeding pattern,side effect and satisfaction with subdermal contraceptive etonogesterel implant(implanon): a comparison between postpartum and non postpartum user
由: Abd. Wahab, Noraziana, et al.
出版: (2013) -
Subdermal etonogestrel: the effects on menses, general health, religious obligations and sexual relationship
由: S I, Sharifah A, et al.
出版: (2015) -
A Successful Removal of a Nonpalpable Etonogestrel Implant
由: Abd Malik, Nur Rashidah, et al.
出版: (2022) -
Subdermal contraceptive implant in post partum women: a prospective study in a single tertiary centre in Pahang, Malaysia: a preliminary study
由: Abd. Wahab, Noraziana, et al.
出版: (2012) -
Sociodemographic profile, contraceptive practice & awareness of HIV infection among unmarried postpartum women in a tertiary centre in Malaysia
由: Mustafa, Kamarul Bahyah, et al.
出版: (2014)